Strategic Alliances

Angiogen has been involved in a non-exclusive collaboration with Genentech for the Phase I Clinical Trial using Genentech's tissue plasminogen activator (tPA) Alteplase® as part of an Angiostatic Cocktail.

Genentech is has provided Alteplase® at no cost to Angiogen.

Angiogen has also conducted clinical research and compassionate use applications using Abbokinase® supplied by Abbott Laboratories. Other strategic partnerships have been established with Northwestern University Medical Center for clinical research.